Page last updated: 2024-09-03

acth (4-10) and Cognition Disorders

acth (4-10) has been researched along with Cognition Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benedict, C; Born, J; Fehm, HL; Hallschmid, M; Kern, W; Perras, B; Schultes, B	1

Other Studies

1 other study(ies) available for acth (4-10) and Cognition Disorders

Article	Year
Towards the therapeutic use of intranasal neuropeptide administration in metabolic and cognitive disorders. Regulatory peptides, 2008, Aug-07, Volume: 149, Issue:1-3 Topics: Adipose Tissue; Administration, Intranasal; Adrenocorticotropic Hormone; Body Weight; Central Nervous System; Cognition Disorders; Female; Humans; Hypoglycemic Agents; Insulin; Male; Melanocyte-Stimulating Hormones; Metabolic Diseases; Neuropeptides; Nootropic Agents; Obesity; Peptide Fragments; Receptors, Melanocortin; Satiety Response; Signal Transduction	2008

Article

Year

Towards the therapeutic use of intranasal neuropeptide administration in metabolic and cognitive disorders.

Regulatory peptides, 2008, Aug-07, Volume: 149, Issue:1-3

Topics: Adipose Tissue; Administration, Intranasal; Adrenocorticotropic Hormone; Body Weight; Central Nervous System; Cognition Disorders; Female; Humans; Hypoglycemic Agents; Insulin; Male; Melanocyte-Stimulating Hormones; Metabolic Diseases; Neuropeptides; Nootropic Agents; Obesity; Peptide Fragments; Receptors, Melanocortin; Satiety Response; Signal Transduction

2008